SEC 13F Intelligence

Checkpoint Capital L.P. / RYTM

Checkpoint Capital L.P.’s Rhythm Pharmaceuticals Inc Position

Does Checkpoint Capital L.P. own Rhythm Pharmaceuticals Inc (RYTM)? Yes — 1.23M shares worth $107M (+38.30% of its 13F portfolio) as of Q1 2026, up from 992.2K shares the prior filed quarter.

Position Value
$107M
Q1 2026
Shares
1.23M
% of Portfolio
+38.30%
Quarters Held
10
currently held

Position History RYTM

Reported value by quarter
Q4 ’23: $34MQ4 ’23Q1 ’24: $36MQ2 ’24: $38MQ2 ’24Q3 ’24: $35MQ4 ’24: $41MQ4 ’24Q1 ’25: $48MQ2 ’25: $67MQ2 ’25Q3 ’25: $77MQ4 ’25: $106MQ4 ’25Q1 ’26: $107Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20261.23M$107M+38.30%
Q4 2025992.2K$106M+33.18%
Q3 2025763.7K$77M+25.84%
Q2 20251.06M$67M+31.21%
Q1 2025907.2K$48M+26.37%
Q4 2024728.0K$41M+20.74%
Q3 2024663.4K$35M+17.24%
Q2 2024922.1K$38M+22.82%
Q1 2024825.5K$36M+23.91%
Q4 2023730.0K$34M+20.33%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Checkpoint Capital L.P.’s full portfolio or all institutional holders of RYTM.